Clinical development
- Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
04 Nov, 2024 - Safety and Immunogenicity Results For Mpox Vaccine MVA-BN in Adolescents Amid Rising Concerns
01 Nov, 2024 - The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol
01 Nov, 2024 - West Oxfordshire GP practices to trial Norovirus vaccine
30 Oct, 2024 - BCRF-Supported DCIS Vaccine Trial
30 Oct, 2024 - Can Roswell Park’s promising brain cancer vaccine work for children and young adults?
30 Oct, 2024 - GSK axes vaccine from $2.1B deal, switching to preclinical successor over ‘increased competition’
30 Oct, 2024 - HIV vaccine candidate successfully optimised for industrial production
30 Oct, 2024 - Children Malaria Vaccination Produce Lower Antibody Titres
30 Oct, 2024 - AIM Vaccine Advances with mRNA RSV Vaccine Approval
29 Oct, 2024 - Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase II trial
29 Oct, 2024 - Naobios and Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production
29 Oct, 2024 - Bavarian Nordic initiates clinical study with mpox vaccine in children
29 Oct, 2024 - NEWS: First Norovirus Vaccine Trials Underway Globally
29 Oct, 2024 - Vaxxas licenses next-gen vaccine antigen for RSV from US NIH
29 Oct, 2024 - Dreams of cancer vaccines are becoming more real. Here are 9 scientists making it happen
29 Oct, 2024 - Clover Biopharmaceuticals’ RSV Vaccine Shows Promising Trial Results
28 Oct, 2024 - Clover announces positive clinical data for RSV Vaccine candidate SCB-1019 compared head-to-Head Versus GSK’s AREXVY
28 Oct, 2024
0 Comments